Evaluation of Continuous Symptom Treatment of ADHD
NCT00486122
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
282
Enrollment
INDUSTRY
Sponsor class
Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG:
Atomoxetine Hydrochloride
DRUG:
Placebo
Sponsor
Eli Lilly and Company